Viewing Study NCT02001623

Bugs

Ignite Creation Date: 2025-12-18 @ 8:21 AM

Ignite Modification Date: 2025-12-23 @ 9:50 PM

Study NCT ID: NCT02001623

Status:

Last Update Posted:

First Post:

Is Possible Gene Therapy: False

Has Adverse Events: False

Brief Title: Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors

Sponsor:

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Contacts Locations Module Design Module Eligibility Module Outcomes Module References Module